RESUMEN
INTRODUCTION: Changes in the composition of the gut microbiota have been associated with the development of Irritable Bowel Syndrome (IBS). However, to what extent specific bacterial species relate to clinical symptoms remains poorly characterized. We investigated the clinical relevance of bacterial species linked with increased proteolytic activity, histamine production, and superantigen (SAg) production in IBS patients. METHODS: Fecal (n=309) and nasal (n=214) samples were collected from patients with IBS and healthy volunteers (HV). Clinical symptoms and gut transit time were evaluated. Bacterial abundance in feces and nasal swabs as well as fecal trypsin-like activity were assessed. RESULTS: The percentage of fecal samples containing Staphylococcus aureus was significantly higher in IBS compared to HV. Forty-nine % of S. aureus-positive fecal samples from patients with IBS were also positive for SAgs, compared to 12% of HV. Patients with IBS and positive fecal SAg-producing S. aureus reported higher pain scores than those without S. aureus. Moreover, increased fecal proteolytic activity was associated with abdominal pain. Fecal abundance of Paraprevotella clara and Alistipes putredinis was significantly decreased in IBS, particularly in samples with higher proteolytic activity. Patients with lower Alistipes putredinis or Faecalibacterium prausnitzii abundance reported more severe abdominal pain. DISCUSSION: In keeping with our preclinical findings, we show that increased presence of SAg-producing S. aureus in fecal samples of patients with IBS is associated with increased levels of abdominal pain. We also show that increased fecal proteolytic activity is associated with increased abdominal pain in patients with IBS.
RESUMEN
Once activated at the surface of cells, G protein-coupled receptors (GPCRs) redistribute to endosomes, where they can continue to signal. Whether GPCRs in endosomes generate signals that contribute to human disease is unknown. We evaluated endosomal signaling of protease-activated receptor-2 (PAR2), which has been proposed to mediate pain in patients with irritable bowel syndrome (IBS). Trypsin, elastase, and cathepsin S, which are activated in the colonic mucosa of patients with IBS and in experimental animals with colitis, caused persistent PAR2-dependent hyperexcitability of nociceptors, sensitization of colonic afferent neurons to mechanical stimuli, and somatic mechanical allodynia. Inhibitors of clathrin- and dynamin-dependent endocytosis and of mitogen-activated protein kinase kinase-1 prevented trypsin-induced hyperexcitability, sensitization, and allodynia. However, they did not affect elastase- or cathepsin S-induced hyperexcitability, sensitization, or allodynia. Trypsin stimulated endocytosis of PAR2, which signaled from endosomes to activate extracellular signal-regulated kinase. Elastase and cathepsin S did not stimulate endocytosis of PAR2, which signaled from the plasma membrane to activate adenylyl cyclase. Biopsies of colonic mucosa from IBS patients released proteases that induced persistent PAR2-dependent hyperexcitability of nociceptors, and PAR2 association with ß-arrestins, which mediate endocytosis. Conjugation to cholestanol promoted delivery and retention of antagonists in endosomes containing PAR2 A cholestanol-conjugated PAR2 antagonist prevented persistent trypsin- and IBS protease-induced hyperexcitability of nociceptors. The results reveal that PAR2 signaling from endosomes underlies the persistent hyperexcitability of nociceptors that mediates chronic pain of IBS. Endosomally targeted PAR2 antagonists are potential therapies for IBS pain. GPCRs in endosomes transmit signals that contribute to human diseases.
Asunto(s)
Dolor Crónico/etiología , Endosomas/fisiología , Síndrome del Colon Irritable/fisiopatología , Receptor PAR-2/fisiología , Transducción de Señal/fisiología , Animales , Endocitosis , Quinasas MAP Reguladas por Señal Extracelular/fisiología , Humanos , Nocicepción , Nociceptores/fisiología , Tripsina/farmacologíaRESUMEN
G protein-coupled receptors (GPCRs) are considered to function primarily at the plasma membrane, where they interact with extracellular ligands and couple to G proteins that transmit intracellular signals. Consequently, therapeutic drugs are designed to target GPCRs at the plasma membrane. Activated GPCRs undergo clathrin-dependent endocytosis. Whether GPCRs in endosomes control pathophysiological processes in vivo and are therapeutic targets remains uncertain. We investigated the contribution of endosomal signaling of the calcitonin receptor-like receptor (CLR) to pain transmission. Calcitonin gene-related peptide (CGRP) stimulated CLR endocytosis and activated protein kinase C (PKC) in the cytosol and extracellular signal regulated kinase (ERK) in the cytosol and nucleus. Inhibitors of clathrin and dynamin prevented CLR endocytosis and activation of cytosolic PKC and nuclear ERK, which derive from endosomal CLR. A cholestanol-conjugated antagonist, CGRP8-37, accumulated in CLR-containing endosomes and selectively inhibited CLR signaling in endosomes. CGRP caused sustained excitation of neurons in slices of rat spinal cord. Inhibitors of dynamin, ERK, and PKC suppressed persistent neuronal excitation. CGRP8-37-cholestanol, but not unconjugated CGRP8-37, prevented sustained neuronal excitation. When injected intrathecally to mice, CGRP8-37-cholestanol inhibited nociceptive responses to intraplantar injection of capsaicin, formalin, or complete Freund's adjuvant more effectively than unconjugated CGRP8-37 Our results show that CLR signals from endosomes to control pain transmission and identify CLR in endosomes as a therapeutic target for pain. Thus, GPCRs function not only at the plasma membrane but also in endosomes to control complex processes in vivo. Endosomal GPCRs are a drug target that deserve further attention.
Asunto(s)
Proteína Similar al Receptor de Calcitonina/genética , Endocitosis/efectos de los fármacos , Endosomas/metabolismo , Nocicepción/fisiología , Dolor/fisiopatología , Transmisión Sináptica/efectos de los fármacos , Antagonistas Adrenérgicos/farmacología , Animales , Péptido Relacionado con Gen de Calcitonina/farmacología , Proteína Similar al Receptor de Calcitonina/antagonistas & inhibidores , Proteína Similar al Receptor de Calcitonina/metabolismo , Capsaicina/antagonistas & inhibidores , Capsaicina/farmacología , Colestanoles/farmacología , Clatrina/antagonistas & inhibidores , Clatrina/genética , Clatrina/metabolismo , Dinaminas/genética , Dinaminas/metabolismo , Endosomas/efectos de los fármacos , Formaldehído/antagonistas & inhibidores , Formaldehído/farmacología , Adyuvante de Freund/antagonistas & inhibidores , Adyuvante de Freund/farmacología , Regulación de la Expresión Génica , Inyecciones Espinales , Masculino , Ratones , Microtomía , Proteína Quinasa 1 Activada por Mitógenos/genética , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Proteína Quinasa 3 Activada por Mitógenos/genética , Proteína Quinasa 3 Activada por Mitógenos/metabolismo , Nocicepción/efectos de los fármacos , Dolor/inducido químicamente , Dolor/genética , Dolor/prevención & control , Fragmentos de Péptidos/farmacología , Proteína Quinasa C/genética , Proteína Quinasa C/metabolismo , Ratas , Médula Espinal/citología , Médula Espinal/efectos de los fármacos , Médula Espinal/metabolismo , Técnicas de Cultivo de TejidosRESUMEN
Winter 2016/2017 was one of the driest on record for central Europe and the United Kingdom. This was the result of blocked atmospheric circulation with high pressure centred over North-West Europe dominating the winter mean circulation pattern. Using large ensembles of simulated winters, we find that the observed winter 2016/2017 circulation was very similar in pattern and strength to the circulation associated with the top 10% of driest Central European winters. Here, we explore whether seasonal forecasts were able to predict this circulation pattern. Despite the fact that the observed circulation anomaly did not project on to the North Atlantic Oscillation (NAO), we find that forecasts starting in November did predict a high-pressure anomaly over North-Western Europe. We use two independent data sets, and methods, to probe the drivers of this circulation pattern. We find evidence for a Rossby Wave propagating out of the tropical Atlantic where there were anomalous local rainfall anomalies. This case study is another example of real-time seasonal forecast skill for Europe and provides evidence for predictability beyond the NAO pattern.
RESUMEN
Ring canals connecting Drosophila germline, follicle and imaginal disc cells provide direct contact of cytoplasm between cells. To date, little is known about the formation, structure, or function of the somatic ring canals present in follicle and imaginal disc cells. Here, we show by confocal and electron microscopy that Pavarotti kinesin-like protein and Visgun are stable components of somatic ring canals. Using live-cell confocal microscopy, we show that somatic ring canals form from the stabilization of mitotic cleavage furrows. In contrast to germline cells, syncytial follicle cells do not divide synchronously, are not maximally branched and their ring canals do not increase in size during egg chamber development. We show for the first time that somatic ring canals permit exchange of cytoplasmic proteins between follicle cells. These results provide insight into the composition and function of ring canals in somatic cells, implying a broader functional significance for syncytial organization of cells outside the germline.
Asunto(s)
Drosophila/metabolismo , Células Gigantes/metabolismo , Discos Imaginales/metabolismo , Animales , Animales Modificados Genéticamente/genética , Animales Modificados Genéticamente/metabolismo , Núcleo Celular/genética , Núcleo Celular/metabolismo , Clonación Molecular , Citoplasma/genética , Citoplasma/metabolismo , Drosophila/genética , Proteínas de Drosophila/metabolismo , Femenino , Células Gigantes/citología , Discos Imaginales/citología , Oogénesis , Folículo Ovárico/citología , Folículo Ovárico/metabolismo , Transporte de Proteínas , TransgenesRESUMEN
Chemical genetic approaches have had a transformative impact on discovery of drug targets for malaria but have primarily been used for parasite targets. To identify human pathways required for intrahepatic development of parasite, we implemented multiplex cytological profiling of malaria infected hepatocytes treated with liver stage active compounds. Some compounds, including MMV1088447 and MMV1346624, exhibited profiles similar to cells treated with nuclear hormone receptor (NHR) agonist/antagonists. siRNAs targeting human NHRs, or their signaling partners identified eight genes that were critical for Plasmodium berghei infection. Knockdown of NR1D2, a host NHR, significantly impaired parasite growth by downregulation of host lipid metabolism. Importantly, treatment with MMV1088447 and MMV1346624 but not other antimalarials, phenocopied the lipid metabolism defect of NR1D2 knockdown. Our data underlines the use of high-content imaging for host-cellular pathway deconvolution, highlights host lipid metabolism as a drug-able human pathway and provides new chemical biology tools for studying host-parasite interactions.
Asunto(s)
Malaria , Parásitos , Animales , Humanos , Hepatocitos/metabolismo , Hígado/metabolismo , Malaria/tratamiento farmacológico , Malaria/metabolismo , Plasmodium berghei/genéticaRESUMEN
Prolonged Ca(2+) entry through Ca(2+) release-activated Ca(2+) (CRAC) channels is crucial in activating the Ca(2+)-sensitive transcription factor NFAT, which is responsible for directing T cell proliferation and cytokine gene expression. To establish whether targeting CRAC might counteract intestinal inflammation, we evaluated the in vitro effect of a selective CRAC inhibitor on T cell cytokine production and T-bet expression by lamina propria mononuclear cells (LPMC) and biopsy specimens from inflammatory bowel disease (IBD) patients. The inhibitory activity of the CRAC blocker was investigated through patch-clamp experiments on rat basophilic leukemia cells and fluorometric imaging plate reader intracellular Ca(2+) assays using thapsigargin-stimulated Jurkat T cells and its detailed selectivity profile defined using a range of in vitro radioligand binding and functional assays. Anti-CD3/CD28-stimulated LPMC and biopsy specimens from 51 patients with IBD were cultured with a range of CRAC inhibitor concentrations (0.01-10 microM). IFN-gamma, IL-2, IL-8, and IL-17 were analyzed by ELISA. T-bet was determined by immunoblotting. We found that the CRAC blocker concentration-dependently inhibited CRAC current in rat basophilic leukemia cells and thapsigargin-induced Ca(2+) influx in Jurkat T cells. A concentration-dependent reduction in T-bet expression and production of IFN-gamma, IL-2, IL-17, but not IL-8, was observed in IBD LPMC and biopsy specimens treated with the CRAC inhibitor. In conclusion, we provide evidence that the suppression of CRAC channel function may dampen the increased T cell response in the inflamed gut, thus suggesting a promising role for CRAC inhibitor drugs in the therapeutic management of patients with IBD.
Asunto(s)
Canales de Calcio/metabolismo , Citocinas/antagonistas & inhibidores , Citocinas/biosíntesis , Enfermedades Inflamatorias del Intestino/inmunología , Enfermedades Inflamatorias del Intestino/patología , Proteínas de Dominio T Box/antagonistas & inhibidores , Subgrupos de Linfocitos T/inmunología , Subgrupos de Linfocitos T/metabolismo , Adulto , Anciano , Animales , Bloqueadores de los Canales de Calcio/farmacología , Línea Celular Tumoral , Humanos , Enfermedades Inflamatorias del Intestino/metabolismo , Mucosa Intestinal/inmunología , Mucosa Intestinal/metabolismo , Mucosa Intestinal/patología , Células Jurkat , Persona de Mediana Edad , Técnicas de Cultivo de Órganos , Técnicas de Placa-Clamp , Ratas , Proteínas de Dominio T Box/fisiología , Subgrupos de Linfocitos T/patología , Adulto JovenRESUMEN
Electrokinetic (EK) remediation is a promising technology for soil decontamination, although basic pH in the soil close to cathode has constrained EK effectiveness due to heavy metal precipitation. This study aimed to enhance copper removal from kaolinite soil by integrating EK with compost (C) as recyclable reactive filter media (RFM) for the first time. Compost placed near the cathode served as an adsorbent to bind copper ions while buffering the advancement of the alkaline front in soil. The total copper removal rate increased from 1.03% in EK to 45.65% in EK-100%C under an electric potential of 10 V. Further experiments conducted by using biochar (BC) and compost/biochar (C + BC) mixture RFM at different ratios showed total Cu removal efficiency decreasing as EK-100%C > EK-(10%BC + 90%C) > EK-(20%BC + 80%C) > EK-(30%BC + 70%C) > EK. The application of a constant electric current of 20.00 mA further enhanced copper removal to 84.09% in EK-100%C although did not show significant enhancement in EK-(BC + C). The compost RFM was regenerated by acid extraction and then reused twice, achieving a total removal of 74.11%. The findings demonstrated compost as a promising and reusable RFM for the efficient removal of copper in contaminated soil.
RESUMEN
Electrokinetic (EK) remediation has been used in the removal of metal ions from contaminated soil. This study focused on integrating the EK technique with different reactive filter media (RFM) of activated carbon (AC) and biochar (BC) for the first time without adding chemicals to facilitate the removal of copper ions from the contaminated kaolinite soil. Tests based on EK, EK coupled with AC (EK-AC), and EK combined with BC (EK-BC) were performed under an electric potential of 10 V, and the overall removal efficiency of copper ions decreased as EK-BC > EK-AC > EK. The results show that 27% of copper in the soil was captured by BC, compared with only 10% by AC. Additional EK-BC test performed under a constant current (20 mA) revealed that the acid front swept across the soil, resulting in 70.6-95.0% copper removal from soil sections 4 to 1 close to the anode region with more copper accumulation in section 5. Similar to the EK-BC test under a fixed voltage, 26% of copper in the soil was captured by BC during EK-BC treatment under a constant current although with a higher energy consumption. Moreover, RFM was regenerated by flushing with an acid solution, achieving 99.3% of copper recovery in BC and 78.4% in AC. Although the permeability of AC-RFM was higher than that of BC-RFM, copper contaminant was more easily leached out from the BC-RFM. The findings demonstrated the feasibility of contaminant entrapment in BC-RFM and recovery by acid leaching, with potential for sustainable soil remediation.
Asunto(s)
Cobre/química , Restauración y Remediación Ambiental/métodos , Contaminantes del Suelo/química , Carbón Orgánico , Cobre/análisis , Electricidad , Técnicas Electroquímicas/métodos , Electrodos , Contaminación Ambiental , Suelo , Contaminantes del Suelo/análisisRESUMEN
In recent times, the perception of functional gastrointestinal disorders such as irritable bowel syndrome (IBS) has shifted fundamentally. Such disorders are now thought of as serious diseases characterized by perturbations in the neuronal regulation of gastrointestinal function. The concept of visceral hypersensitivity, the characterization of neuronal networks in the 'brain-gut axis' and the identification of several novel 5-HT-mediated mechanisms have contributed to this shift. Here, we review how some of the more promising of these new mechanisms (e.g. those involving 5-HT transporters and the 5-HT(2B), 5-HT(7) and putative 5-HT(1p) receptors) might lead to a range of second-generation therapies that could revolutionize the treatment of functional gastrointestinal disorders, particularly IBS.
Asunto(s)
Sistema Nervioso Entérico/metabolismo , Tracto Gastrointestinal/fisiología , Neurofarmacología , Serotonina/metabolismo , Animales , Enfermedades Gastrointestinales/tratamiento farmacológico , Enfermedades Gastrointestinales/fisiopatología , Tracto Gastrointestinal/efectos de los fármacos , Humanos , Serotonina/fisiologíaRESUMEN
BACKGROUND: Constipation is a prevalent gastrointestinal disorder. Patient dissatisfaction with prescribed medications is common, and there is need for alternative management strategies. Evidence shows that Bifidobacterium species may be beneficial in constipation. AIM: To investigate changes in physiological and clinical measures of gut function in patients with chronic constipation following the consumption of Bifidobacterium lactis NCC2818, compared to placebo. METHODS: Participants were randomised to a 4-week supplementation with B. lactis NCC2818 (1.5 x 1010 CFU/d) or placebo. Gut transit time was measured using a radio-opaque marker, while symptoms and quality of life were assessed using validated questionnaires. Gut microbiota composition was assessed using quantitative polymerase chain reaction. Analysis of covariance was used for normally distributed variables, and Mann-Whitney test for non-normally distributed variables. RESULTS: Seventy-five participants were randomised. There was no significant difference between the probiotic and placebo groups in gut transit time change from baseline to week 2 (-11.7 hours, SD 33.0 hours vs -12.9 hours, SD 33.6 hours; P = 0.863) or to week 4 (-20.4 hours, SD 32.5 h vs -8.7 hours, SD 33.8 hours; P = 0.103). There were also no improvements in stool output, symptoms, or quality of life. No differences were found in Bifidobacterium concentrations between the probiotic and placebo groups at week 4 (9.5 log10 /g dry faeces, SD 0.3 vs 9.4 log10 /g, SD 1.0; P = 0.509). CONCLUSIONS: Bifidobacterium lactis NCC2818 was not effective in the management of mild chronic constipation. This study highlights the importance of further studies and their publication to better understand the strain-specific effects of probiotics.
Asunto(s)
Bifidobacterium , Estreñimiento/terapia , Microbioma Gastrointestinal , Probióticos/uso terapéutico , Adulto , Bifidobacterium animalis , Estreñimiento/microbiología , Método Doble Ciego , Femenino , Enfermedades Gastrointestinales/terapia , Humanos , Masculino , Persona de Mediana Edad , Calidad de Vida , Encuestas y Cuestionarios , Adulto JovenRESUMEN
Identification of novel drug molecules requires the extensive evaluation in vitro and in vivo. Following in vitro evaluation it is necessary to efficiently screen numerous novel molecules in vivo using relatively simple methodology that requires small numbers of animals, is rapid to perform, and provides results that can definitely discriminate potential candidates for further investigation. Herein, we describe the results of three standard compounds (omeprazole, a proton pump inhibitor; cimetidine, an histamine H(2) receptor antagonist; and AR-H047108, a potassium competitive acid blocker) in the rat aspiration model (under both basal and stimulated conditions), and compared the effects with those in the pyloric ligation model with a view to comparing the results in terms of sensitivity, robustness and simplicity of the methodology. In the aspiration model, drug or vehicle was administered orally 1 h prior to administration of pentagastrin or dimaprit. Ten minutes later 0.9% NaCl was administered orally and immediately recovered by aspiration. In the pyloric ligation model, drugs or vehicle were administered orally 2 h before ligation in a volume of 10 ml/kg. For each model, the volume of each sample was measured and the acidity was determined. In the aspiration model under basal acid secretion or following stimulation with pentagastrin omeprazole, cimetidine and AR-H047108 produced dose related inhibition of acidity. Omeprazole and cimetidine inhibited acid secretion following stimulation with dimaprit. In the pyloric ligation model omeprazole, cimetidine and AR-H047108 inhibited acid secretion. The profile of each of 3 inhibitors of acid secretion exhibited similar effects irrespective of the degree of stimulation (dimaprit, pentagastrin or pyloric ligation). Thus, based on these robust effects and ease of methodology we would recommend the use of the rat aspiration model with pentagastrin stimulation of gastric acid secretion as the primary in vivo methodology to screen novel inhibitors of acid secretion.
Asunto(s)
Evaluación Preclínica de Medicamentos , Ácido Gástrico/metabolismo , Fármacos Gastrointestinales/farmacología , Estómago/efectos de los fármacos , Administración Oral , Animales , Cimetidina/farmacología , Estado de Conciencia , Dimaprit/administración & dosificación , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos/métodos , Determinación de la Acidez Gástrica , Mucosa Gástrica/metabolismo , Fármacos Gastrointestinales/administración & dosificación , Antagonistas de los Receptores H2 de la Histamina/farmacología , Imidazoles/farmacología , Ligadura , Masculino , Modelos Animales , Omeprazol/farmacología , Pentagastrina/administración & dosificación , Inhibidores de la Bomba de Protones/farmacología , Piridinas/farmacología , Ratas , Ratas Wistar , Reproducibilidad de los Resultados , Estómago/cirugía , SucciónRESUMEN
AIM: To evaluate measurements of intragastric pH with the Bravo capsule system over a prolonged time. METHODS: A Bravo capsule was placed inside the rat gastric body and pH was studied for periods up to five consecutive days. For comparison, a gastric fistula model was used. Effects of ghrelin and esomeprazole, with or without pentagastrin, on gastric pH were studied. In addition, effects of esomeprazole on plasma ghrelin, gastrin and somatostatin were analyzed. RESULTS: All rats recovered after surgery. The average 24-h pH during free feeding was 2.3 +/- 0.1 (n = 20) with a variation of 18% +/- 6% over 5 d. Ghrelin, 2400 pmol/kg, t.i.d. increased pH from 1.7 +/- 0.1 to 3.1 +/- 0.3 (P < 0.01) as recorded with the Bravo system. After esomeprazole (1 mg/kg, 3 mg/kg and 5 mg/kg) there was a dose-dependent pH increase of maximally 3.4 +/- 0.1, with day-to-day variation over the entire period of 8% +/- 3%. The fistula and pH studies generated similar results. Acid inhibition with esomeprazole increased plasma ghrelin from 10 +/- 2 pmol/L to 65 +/- 26 pmol/L (P < 0.001), and somatostatin from 10 +/- 2 pmol/L to 67 +/- 18 pmol/L (P < 0.001). CONCLUSION: pH measurements with the Bravo capsule are reliable, and comparable to those of the gastric fistula model. The Bravo system optimizes accurate intragastric pH monitoring over prolonged periods and allows both short- and long-term evaluation of effects of drugs and hormones.
Asunto(s)
Endoscopios en Cápsulas , Endoscopía Capsular , Ácido Gástrico/metabolismo , Determinación de la Acidez Gástrica/instrumentación , Fístula Gástrica/fisiopatología , Mucosa Gástrica/metabolismo , Hormonas Gastrointestinales/metabolismo , Ghrelina/metabolismo , Animales , Modelos Animales de Enfermedad , Esomeprazol/farmacología , Fístula Gástrica/metabolismo , Mucosa Gástrica/efectos de los fármacos , Gastrinas/metabolismo , Fármacos Gastrointestinales/farmacología , Concentración de Iones de Hidrógeno , Masculino , Monitoreo Ambulatorio/instrumentación , Pentagastrina/farmacología , Inhibidores de la Bomba de Protones/farmacología , Ratas , Ratas Sprague-Dawley , Reproducibilidad de los Resultados , Somatostatina/metabolismo , Telemetría/instrumentación , Factores de TiempoRESUMEN
Chronic constipation (CC) remains a common gastrointestinal (GI) disorder that conveys a substantial healthcare burden. Expert guidelines recommend increasing fiber intake, yet the clinical evidence to support this needs strengthening for specific fibers. The aim was to evaluate changes in intestinal transit time and GI symptoms in CC patients who consumed polydextrose. In a randomized, double-blind, placebo-controlled trial, 128 adults with CC received 8 g or 12 g polydextrose, or placebo, daily for 4 weeks. Transit time, as primary outcome, was assessed by radiopaque marker distribution after 2-weeks intervention. Bowel habits, GI symptoms and quality of life (QOL) were assessed by questionnaire, including the Patient-Assessment of Constipation (PAC) Symptoms (SYM), and PAC-QOL. Following 2-weeks intervention, no reduction was seen in transit time in any group and following 2- or 4-weeks intervention, no improvements were seen in stool frequency or consistency in any group. After 2-weeks intervention with 8 g/day polydextrose an improvement was seen in the PAC-SYM rectal score (p = 0.041). After 4-weeks intervention both rectal (p = 0.049) and stool (p = 0.029) scores improved while improvement in the QOL satisfaction score did not reach significance (p = 0.071). Overall, the results suggest that 2-weeks consumption of 8 or 12 g/day polydextrose does not significantly improve physiological measures of gut function in CC adults. Longer term consumption may improve clinical measures, but further studies will be required to substantiate this.
Asunto(s)
Estreñimiento/terapia , Fibras de la Dieta/uso terapéutico , Suplementos Dietéticos , Tránsito Gastrointestinal , Glucanos/uso terapéutico , Intestinos/fisiopatología , Dolor Abdominal/etiología , Dolor Abdominal/prevención & control , Adulto , Anciano , Estreñimiento/fisiopatología , Fibras de la Dieta/administración & dosificación , Fibras de la Dieta/efectos adversos , Método Doble Ciego , Femenino , Glucanos/administración & dosificación , Glucanos/efectos adversos , Humanos , Análisis de Intención de Tratar , Masculino , Persona de Mediana Edad , Pacientes Desistentes del Tratamiento , Calidad de Vida , Autoinforme , Índice de Severidad de la Enfermedad , Adulto JovenRESUMEN
Irritable bowel syndrome (IBS) is a common disorder characterized by altered gut function and often is accompanied by comorbid anxiety. Although changes in the gut microbiota have been documented, their relevance to the clinical expression of IBS is unknown. To evaluate a functional role for commensal gut bacteria in IBS, we colonized germ-free mice with the fecal microbiota from healthy control individuals or IBS patients with diarrhea (IBS-D), with or without anxiety, and monitored gut function and behavior in the transplanted mice. Microbiota profiles in recipient mice clustered according to the microbiota profiles of the human donors. Mice receiving the IBS-D fecal microbiota showed a taxonomically similar microbial composition to that of mice receiving the healthy control fecal microbiota. However, IBS-D mice showed different serum metabolomic profiles. Mice receiving the IBS-D fecal microbiota, but not the healthy control fecal microbiota, exhibited faster gastrointestinal transit, intestinal barrier dysfunction, innate immune activation, and anxiety-like behavior. These results indicate the potential of the gut microbiota to contribute to both intestinal and behavioral manifestations of IBS-D and suggest the potential value of microbiota-directed therapies in IBS patients.
Asunto(s)
Conducta Animal , Trasplante de Microbiota Fecal , Heces/microbiología , Tracto Gastrointestinal/fisiopatología , Síndrome del Colon Irritable/microbiología , Adulto , Animales , Ansiedad/sangre , Ansiedad/metabolismo , Ansiedad/fisiopatología , Estudios de Casos y Controles , Colon/inmunología , Colon/microbiología , Femenino , Microbioma Gastrointestinal , Tránsito Gastrointestinal , Vida Libre de Gérmenes , Humanos , Masculino , Metabolómica , Ratones , Donantes de TejidosRESUMEN
Activation of protease-activated receptor (PAR)-2 has been proposed to be protective in myocardial ischemia/reperfusion (I/R) injury, an effect possibly related to an action on the coronary vasculature. Therefore, we investigated the effects of PAR2 activation on coronary tone in isolated perfused rat hearts and elucidated the mechanisms of any observed effects. Although having a negligible effect on ventricular contractility, the PAR2 activating peptide SLIGRL produced an endothelium-dependent coronary vasodilatation (ED(50)=3.5 nmol). Following I/R injury, the response to SLIGRL was selectively preserved, whereas the dilator response to acetylcholine was converted to constriction. Trypsin also produced a vasodilator dose-response curve that was biphasic in nature (ED(50-1)=0.36 U, ED(50-2)=38.71 U). Desensitization of PAR2 receptors indicated that the high potency phase was mediated by PAR2. Removal of the endothelium but not treatment with L-NAME (300 micromol/L), indomethacin (5 micromol/L), or oxyhemoglobin (10 micromol/L) inhibited the response to SLIGRL and trypsin. Treatment with the K(+)-channel blockers TEA (10 mmol/L), charybdotoxin (20 nmol/L)/apamin (100 nmol/L), or elevated potassium (20 mmol/L) significantly suppressed responses. Similarly, inhibition of lipoxygenase with nordihydroguaiaretic acid (1 micromol/L), eicosatetraynoic acid (1 micromol/L), or baicalein (10 micromol/L), desensitization of C-fibers using capsaicin (1 micromol/L, 20 minutes), or blockade of vanilloid (VR1) receptors using capsazepine (3 micromol/L) inhibited the responses. This study shows, for the first time, that PAR2 activation causes endothelium-dependent coronary vasodilation that is preserved after I/R injury and is not mediated by NO or prostanoids, but involves the release of an endothelium-derived hyperpolarizing factor (EDHF), possibly a lipoxygenase-derived eicosanoid, and activation of VR1 receptors on sensory C-fibers.
Asunto(s)
Factores Biológicos/metabolismo , Capsaicina/análogos & derivados , Vasos Coronarios/metabolismo , Receptores de Trombina/metabolismo , Vasodilatación/efectos de los fármacos , Acetilcolina/farmacología , Animales , Capsaicina/farmacología , Vasos Coronarios/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/farmacología , Técnicas In Vitro , Lipooxigenasa/metabolismo , Masculino , Contracción Miocárdica/efectos de los fármacos , Isquemia Miocárdica/fisiopatología , Daño por Reperfusión Miocárdica/fisiopatología , Fibras Nerviosas/efectos de los fármacos , Fibras Nerviosas/fisiología , Oligopéptidos/farmacología , Potasio/farmacología , Bloqueadores de los Canales de Potasio/farmacología , Ratas , Ratas Wistar , Receptor PAR-2 , Receptores de Droga/metabolismo , Receptores de Trombina/efectos de los fármacos , Tripsina/farmacología , Vasodilatación/fisiologíaRESUMEN
BACKGROUND: Systemic hypotension as a consequence of vascular dysfunction is a well-recognized and important feature of critical illness. Although serine protease activation has been implicated as a cause of vascular dysfunction in systemic inflammation, the mechanism is unknown. Recently, a class of receptors with an entirely novel mechanism of action, protease-activated receptors (PARs), has been identified that would explain the link between protease activation and systemic hypotension. Our aim was to test the hypothesis that in vivo activation of protease-activated receptor 2 (PAR-2) in humans would mediate vasodilatation. METHODS AND RESULTS: For these first-in-human studies, an activating peptide for the human PAR-2 receptor was synthesized and administered to healthy volunteers. Using both the dorsal hand vein technique and forearm plethysmography, we studied the effects of PAR-2 activation in human blood vessels and investigated the mechanism of vasodilation. Activation of PAR-2 receptors in vivo dilated human blood vessels in a dose-dependent manner, and the effects were reduced by inhibition of both nitric oxide and prostanoid synthesis CONCLUSIONS: These findings demonstrate that serine protease activity can cause human vasodilation and provide a possible explanation of why serine protease activation in critical illness is associated with vascular dysfunction.
Asunto(s)
Óxido Nítrico/fisiología , Oligopéptidos/farmacología , Prostaglandinas/fisiología , Receptores de Trombina/fisiología , Vasodilatación , Aspirina/farmacología , Inhibidores de la Ciclooxigenasa/farmacología , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/farmacología , Femenino , Humanos , Masculino , Óxido Nítrico Sintasa/antagonistas & inhibidores , Oligopéptidos/sangre , Receptor PAR-2 , Vasodilatación/efectos de los fármacos , omega-N-Metilarginina/farmacologíaRESUMEN
The efficacy of contemporary cognitive therapy for obsessive-compulsive disorder (OCD) has only recently been investigated. The current study compares exposure and response prevention (ERP) and cognitive behavior therapy (CBT) delivered in an individual format. Participants were randomly assigned to the 12 consecutive-week CBT or ERP treatment. Based on 59 treatment completers, there was no significant difference in YBOCS scores between CBT and ERP at post-treatment or at 3-month follow-up. A higher percentage of CBT participants obtained recovered status at post-treatment (67%) and at follow-up (76%), compared to ERP participants (59% and 58%, respectively), but the difference was not significant. Effect sizes (ESs) were used to compare the results of the current study with a previous study conducted at our center that utilized group CBT and ERP treatments, as well as other controlled trials that have compared CBT and ERP. The significance of these results is discussed and a comparison is made with the existing literature.
Asunto(s)
Terapia Cognitivo-Conductual/métodos , Desensibilización Psicológica/métodos , Trastorno Obsesivo Compulsivo/terapia , Adolescente , Adulto , Anciano , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Trastorno Obsesivo Compulsivo/psicología , Escalas de Valoración Psiquiátrica , Psicoterapia de Grupo/métodos , Resultado del TratamientoRESUMEN
Severe pododermatitis is a common lesion in turkeys, unlike in broiler chickens. Both dietary factors (soybean meal, biotin, methionine) and poor litter conditions (wet litter) are documented etiologies of footpad lesions. In the United States and United Kingdom both farm managers and processors monitor lesions. The United Kingdom reports an average footpad relative score higher than that of the United States. In both countries, incidence in toms is higher than in hens. There is no significant difference by country. Data support no consistent association with other lesions (i.e., breast blisters or condemnations), breed, or performance parameters (i.e., weight gain or age). The litter type used in the United Kingdom is either straw or wood shavings, whereas in the United States producers predominantly use wood shavings. In the United Kingdom, diets are formulated with a higher protein, which affects the excreta and subsequent litter conditions. British United Turkey is the predominate breed in the United Kingdom. In the United States, three breeds, British United Turkey of America, hybrid, and Nicholas, are common. Recent research has demonstrated the association between biotin levels and pododermatitis. Factors associated with pododermatitis (such as production systems, wet litter, and stocking density) are discussed. There are some indications that increased stocking density is associated with pododermatitis lesions. Further research is needed to identify what management factors are associated with pododermatitis.